FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry and represents medication, which has a nootropic action on an organism based on cyclic dipeptides, which contains a propyl-alanine sequence.
EFFECT: invention ensures extension of arsenal of medication with nootropic activity.
2 cl, 2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIHYPOXIC, NEUROPROTECTIVE AND ANTIAMNESTIC ACTIVITY | 2012 |
|
RU2480233C1 |
| NOVEL GLYPROLINS WITH NOOTROPIC, ANTI-HYPOXIC, NEUROPROTECTIVE AND ANSSIYLITIS ACTIVITY | 2016 |
|
RU2646604C2 |
| CYCLIC INHIBITORS OF ADHESION | 1993 |
|
RU2116081C1 |
| METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
| AGENT HAVING NOOTROPIC EFFECT ON BODY | 2017 |
|
RU2694233C2 |
| CYCLOPEPTIDES, A METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEIR AND A METHOD OF THEIR PREPARING | 1994 |
|
RU2130030C1 |
| PEPTIDE USED FOR INHIBITION OF PEPSIN RELEASE, PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2144038C1 |
| CYCLIC PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2095368C1 |
| IMPROVING THE RECOVERY FUNCTION OF THE CARDIOVASCULAR SYSTEM IN ISCHEMIA TETRADECAPEPTIDES | 2017 |
|
RU2648846C1 |
| PRODRUGS CONTAINING HYALURONIC ACID CONJUGATE, LINKER AND DOUBLE AGONIST GLP-1/GLUCAGON | 2016 |
|
RU2719482C2 |
